Literature DB >> 21555910

The role of holocarboxylase synthetase in genome stability is mediated partly by epigenomic synergies between methylation and biotinylation events.

Janos Zempleni1, Yong Li, Jing Xue, Elizabeth L Cordonier.   

Abstract

Holocarboxylase synthetase (HLCS) catalyzes the covalent binding of biotin to histones. Biotinylated histones are gene repression marks and are particularly enriched in long terminal repeats, telomeres, and other repeat regions. The effects of HLCS in gene regulation are mediated by its physical interactions with chromatin proteins such as histone H3, DNMT1, MeCP2, and EHMT-1. It appears that histone biotinylation depends on prior methylation of cytosines. De-repression of long terminal repeats in biotin- or HLCS-deficient cell cultures and organisms is associated with genome instability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555910      PMCID: PMC3154430          DOI: 10.4161/epi.6.7.15544

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  42 in total

1.  The polypeptide Syn67 interacts physically with human holocarboxylase synthetase, but is not a target for biotinylation.

Authors:  Yousef I Hassan; Hideaki Moriyama; Janos Zempleni
Journal:  Arch Biochem Biophys       Date:  2009-12-21       Impact factor: 4.013

2.  Biotin regulates the expression of holocarboxylase synthetase in the miR-539 pathway in HEK-293 cells.

Authors:  Baolong Bao; Rocio Rodriguez-Melendez; Subhashinee S K Wijeratne; Janos Zempleni
Journal:  J Nutr       Date:  2010-06-30       Impact factor: 4.798

3.  Holocarboxylase synthetase is a chromatin protein and interacts directly with histone H3 to mediate biotinylation of K9 and K18.

Authors:  Baolong Bao; Valerie Pestinger; Yousef I Hassan; Gloria E O Borgstahl; Carol Kolar; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2010-08-05       Impact factor: 6.048

4.  Identification of holocarboxylase synthetase chromatin binding sites in human mammary cell lines using the DNA adenine methyltransferase identification technology.

Authors:  Dipika Singh; Angela K Pannier; Janos Zempleni
Journal:  Anal Biochem       Date:  2011-03-06       Impact factor: 3.365

5.  Novel histone biotinylation marks are enriched in repeat regions and participate in repression of transcriptionally competent genes.

Authors:  Valerie Pestinger; Subhashinee S K Wijeratne; Rocio Rodriguez-Melendez; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2010-08-06       Impact factor: 6.048

6.  Functional analysis and identification of cis-regulatory elements of human chromosome 21 gene promoters.

Authors:  Hans-Jörg Warnatz; Robert Querfurth; Anna Guerasimova; Xi Cheng; Stefan A Haas; Andrew L Hufton; Thomas Manke; Dominique Vanhecke; Wilfried Nietfeld; Martin Vingron; Michal Janitz; Hans Lehrach; Marie-Laure Yaspo
Journal:  Nucleic Acids Res       Date:  2010-05-21       Impact factor: 16.971

7.  Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions.

Authors:  Eva Darai-Ramqvist; Agneta Sandlund; Stefan Müller; George Klein; Stefan Imreh; Maria Kost-Alimova
Journal:  Genome Res       Date:  2008-01-29       Impact factor: 9.043

8.  K12-biotinylated histone H4 is enriched in telomeric repeats from human lung IMR-90 fibroblasts.

Authors:  Subhashinee S K Wijeratne; Gabriela Camporeale; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2009-04-14       Impact factor: 6.048

9.  Nonenzymatic biotinylation of histone H2A.

Authors:  Shannon Healy; Tom D Heightman; Laura Hohmann; David Schriemer; Roy A Gravel
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

10.  The role of histone H4 biotinylation in the structure of nucleosomes.

Authors:  Nina A Filenko; Carol Kolar; John T West; S Abbie Smith; Yousef I Hassan; Gloria E O Borgstahl; Janos Zempleni; Yuri L Lyubchenko
Journal:  PLoS One       Date:  2011-01-27       Impact factor: 3.240

View more
  1 in total

Review 1.  The quest for an effective and safe personalized cell therapy using epigenetic tools.

Authors:  T A L Brevini; G Pennarossa; E F M Manzoni; C E Gandolfi; A Zenobi; F Gandolfi
Journal:  Clin Epigenetics       Date:  2016-11-16       Impact factor: 6.551

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.